- Home
- TMHC vs PCVX Comparison
TMHC vs PCVX Comparison
Compare TMHC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMHC | PCVX |
|---|---|---|
| Founded | 1936 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.1B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TMHC | PCVX |
|---|---|---|
| Price | $65.47 | $53.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $78.25 | ★ $97.67 |
| AVG Volume (30 Days) | 895.0K | ★ 1.5M |
| Earning Date | 02-11-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.21 | N/A |
| EPS | ★ 8.31 | N/A |
| Revenue | ★ $8,378,329,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.65 | ★ N/A |
| Revenue Growth | ★ 6.98 | N/A |
| 52 Week Low | $51.90 | $27.66 |
| 52 Week High | $72.50 | $91.77 |
Technical Indicators
Market Signals| Indicator | TMHC | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 63.64 | 58.94 |
| Support Level | $59.89 | $51.10 |
| Resistance Level | $62.29 | $58.95 |
| Average True Range (ATR) | 2.08 | 3.34 |
| MACD | 0.12 | 0.42 |
| Stochastic Oscillator | 83.75 | 64.56 |
Price Performance
Historical ComparisonAbout TMHC Taylor Morrison Home Corporation
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.